In collaboration with Deepa Rao at Pacific entitled “Mitigation of Doxorubicin-Induced Cardiotoxicity by Phytochemicals in Micelles” Congratulations!
Despite its promising therapeutic potential, nanoparticle-mediated magnetic hyperthermia is currently limited to the treatment of localized and relatively accessible cancer tumors because the required therapeutic temperatures above 40 °C can only be achieved by direct intratumoral injection of conventional iron oxide nanoparticles. To realize the true potential of magnetic hyperthermia for cancer treatment, there is […]
Dr. Oleh Taratula, an associate professor of Nanotherapeutics in the Department of Pharmaceutical Sciences based on our Portland campus, received a 5-year, $2.3 million R01 grant from the National Cancer Institute, National Institutes of Health. Dr. Taratula’s project, “Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia,” is to develop a treatment for the weight loss […]
Dr. Jon (JJ) Furuno, associate professor and interim chair of the Department of Pharmacy Practice, is the PI of a new 3-year, $1.5 million R01 award from the Agency for Healthcare Research and Quality (AHRQ) to develop an intervention bundle to improve antibiotic prescribing on discharge from hospital to long-term care facilities. This study includes […]
Drs. Jane Ishmael and Kerry McPhail, Associate Professors of Pharmacology and Medicinal Chemistry/Natural Products, respectively, in the Department of Pharmaceutical Sciences, received NIH R01 funding for $1.6 million to pursue natural products drug discovery research for a project titled “Modulation of Protein Biogenesis and Secretion by Natural Product Translocon Ligands.” Drs. Ishmael and McPhail are […]
Dr. Gaurav Sahay, an assistant professor of Drug Delivery and Nanotherapeutics in the Department of Pharmaceutical Sciences based on our Portland campus, received a 5-year, $3.3 million R01 grant from National Institutes of Health. Sahay’s project, “Nanoparticle-based mRNA delivery for treatment of cystic fibrosis,” is to develop a novel, inhalable system capable of delivering mRNA […]